공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 차세대 시퀀싱(NGS) 시장 예측(-2026년) : 제품 및 서비스(소모품, 플랫폼, 서비스, 바이오인포매틱스), 기술(SBS, SMRT), 용도(진단, Drug Discovery, 농업), 최종사용자(제약, 바이오테크놀러지, 학술), 지역별

Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic)- Global Forecast to 2026

리서치사 MarketsandMarkets
발행일 2021년 04월 상품 코드 1001969
페이지 정보 영문 377 Pages
가격
US $ 4,950 ₩ 5,680,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,630,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,352,000 PDF (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,475,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 차세대 시퀀싱(NGS) 시장 예측(-2026년) : 제품 및 서비스(소모품, 플랫폼, 서비스, 바이오인포매틱스), 기술(SBS, SMRT), 용도(진단, Drug Discovery, 농업), 최종사용자(제약, 바이오테크놀러지, 학술), 지역별 Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic)- Global Forecast to 2026
발행일 : 2021년 04월 페이지 정보 : 영문 377 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 차세대 시퀀싱(NGS) 시장 규모는 예측기간 중 18.7%의 CAGR로 확대되고, 2021년 103억 달러에서 2026년에는 242억 달러 규모로 성장할 것으로 예측됩니다. 첨단 NGS 시스템의 저비용으로의 이용 가능성, 정밀의료에 유리한 자금 조달 시나리오 등의 요인이 시장 성장을 추진하고 있습니다.

제품 및 서비스별로는 소모품 부문이 2020년에 최대의 점유율을 나타내고 있습니다.

처리 건수 증가와 사용하기 쉬운 소모품 발매 등의 요인이 이 부문의 성장을 견인하고 있습니다. 또한 지역별로는 아시아태평양이 예측기간 중 최대의 CAGR로 성장할 것으로 예측됩니다. NGS 기반 연구 프로젝트 증가, 암 증례수 증가, 정밀의료에 대한 주력 확대 등이 이 지역의 성장을 견인할 전망입니다.

세계의 차세대 시퀀싱(NGS : Next-generation Sequencing) 시장을 조사했으며, 시장 정의와 개요, 밸류체인, 신종 코로나바이러스 감염증(COVID-19) 및 기타 시장 영향요인 분석, 규제 상황, 기술·특허 동향, 시장 규모 추정과 예측, 제품 및 서비스·기술·용도·최종사용자·지역/주요 국가별 내역, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
    • 동향
  • COVID-19의 영향
  • Porter's Five Forces 분석
  • 밸류체인 분석
  • 기술 분석
  • 생태계 분석
  • 특허 분석
  • 가격 분석
  • 규제 분석

제6장 시장 분석과 예측 : 제품·서비스별

  • 소모품
  • 시퀀싱 서비스
    • 엑솜 및 타겟 리시퀀싱·커스텀 패널
    • 전게놈 시퀀싱·DE NOVO 시퀀싱
    • RNA 시퀀싱
    • 기타
  • 준비 제품 및 서비스·샘플 조제
    • 라이브러리 준비·타겟 강화
    • 품질 관리
  • NGS 플랫폼
    • ILLUMINA
    • THERMO FISHER SCIENTIFIC
    • OXFORD NANOPORE TECHNOLOGIES
    • PACIFIC BIOSCIENCES
    • 기타
  • 바이오인포매틱스
    • NGS 데이터 분석 서비스
    • NGS 데이터 분석 소프트웨어·워크벤치
    • NGS 보관·관리·클라우드 컴퓨팅 솔루션
  • NGS 플랫폼용 서비스

제7장 시장 분석과 예측 : 기술별

  • SBS(Sequencing By Synthesis)
  • 이온 반도체 시퀀싱
  • 나노포어 시퀀싱
  • 단일 분자 실시간 시퀀싱
  • 기타

제8장 시장 분석과 예측 : 용도별

  • 진단
    • 감염증
    • 생식기능
    • 기타
  • Drug Discovery
  • 농업·동물 연구
  • 기타

제9장 시장 분석과 예측 : 최종사용자별

  • 학술기관·연구 센터
  • 제약·바이오테크놀러지 기업
  • 병원·클리닉
  • 기타

제10장 시장 분석과 예측 : 지역·주요 국가별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 호주
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동 및 아프리카

제11장 경쟁 상황

  • 개요
  • 시장 평가 체계
  • 시장 점유율 분석
  • 주요 기업의 매출 점유율 분석
  • 기업 평가 쿼드런트
  • 기업 평가 쿼드런트 : 스타트업/중소기업
  • 기업의 제품 발자국
  • 기업의 지역적 발자국
  • 경쟁 시나리오

제12장 기업 개요

  • 주요 기업
    • ILLUMINA, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • BGI GROUP
    • PERKINELMER
    • QIAGEN N.V.
    • F. HOFFMANN-LA ROCHE AG
    • EUROFINS SCIENTIFIC
    • AGILENT TECHNOLOGIES, INC.
    • PACIFIC BIOSCIENCES
    • OXFORD NANOPORE TECHNOLOGIES
    • GENEWIZ
    • PSOMAGEN, INC.
    • 10X GENOMICS
    • NUGEN TECHNOLOGIES
    • ZYMO RESEARCH
    • TAKARA BIO
  • 기타 유력 기업
    • HAMILTON COMPANY
    • BECKMAN COULTER
    • BECTON, DICKINSON AND COMPANY
    • GENOTYPIC TECHNOLOGY
    • LUCIGEN CORPORATION

제13장 부록

KSM 21.04.30

The next-generation sequencing market is projected to reach USD 24.2 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 18.7% during the forecast period, owing to availability of advanced NGS systems at low costs, and favorable funding scenario for precision medicine.

"By product & service, the NGS consumables segment accounted for the largest share of the next-generation sequencing market"

The next-generation sequencing market by product is categorized into major consumables and equipments. NGS consumables dominated the market in 2020. The large share of this segment can be attributed to growing number of sequencing procedures and launch of easy-to-use consumables.

"Asia Pacific: The fastest-growing region in the next-generation sequencing market."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to increasing number of NGS-based research projects, growing number of cancer cases, and rising awareness about precision medicine.

"North America: the largest share of the next-generation sequencing market"

North America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondent- Supply Side- 70%, Demand Side- 30%
  • By Designation- Executives- 25%, CXOs, Directors--30%, Managers - 45%
  • By Region- North America - 40%, Europe - 25%, APAC - 20%, LATAM- 10%, MEA- 5%

The next-generation sequencing market is dominated by a few globally established players such as Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), GENEWIZ (US), Psomagen, Inc. (South Korea), 10x Genomics (US), Takara Bio (Japan), Zymo Research (US), NuGen Technologies (US), Hamilton Company (US), Beckman Coulter (US), Becton, Dickinson, and Company (US), Lucigen Corporation (US), and Novogene Co., Ltd. (China).

Research Coverage:

The report segments the next-generation sequencing market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), Product & Service (NGS Consumables, Sequencing Services (Exome & Targeted Resequencing & Custom Panels, Whole-Genome Sequencing & De Novo Sequencing, RNA Sequencing, Other Sequencing Services), Presequencing Products & Services (Library Preparation & Target Enrichment, Quality Control), NGS Platforms (Illumina (Novaseq Systems, Nextseq Systems, Miseq Systems, Miniseq Systems, iSeq Systems), Thermo Fisher Scientifi (ION PGM Systems, ION Proton Systems, ION Genestudio Systems, Ion Torrent Genexus Systems), Oxford Nanopore Technologies, Pacific Biosciences, Other Platforms), Bioinformatics, Services for NGS Platforms), Bioinformatics (Data Analysis Services, NGS Data Analysis Software & Workbenches, NGS Storage, Management, & Cloud Computing Solutions), Technology (Sequencing by Synthesis, ION Semiconductor Sequencing, Nanopore Sequencing, Single-Molecule Real-Time Sequencing, Other Technologies), Application (Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications), Drug Discovery, Agricultural & Animal Research, Other Applications), End User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Other End Users)

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the next-generation sequencing market

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the next-generation sequencing market and provides them information on key market drivers, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • FIGURE 1 NEXT-GENERATION SEQUENCING MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
    • FIGURE 3 NEXT-GENERATION SEQUENCING MARKET: BREAKDOWN OF PRIMARIES
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
    • FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020
    • FIGURE 6 NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS, 2021-2026
    • FIGURE 7 NEXT-GENERATION SEQUENCING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NEXT-GENERATION SEQUENCING MARKET

4 PREMIUM INSIGHTS

  • 4.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW
    • FIGURE 14 ADVANCEMENTS IN NGS PLATFORMS TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020)
    • FIGURE 15 NGS CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN NGS MARKET IN 2020
  • 4.3 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE THE NGS MARKET IN 2026
  • 4.4 NEXT-GENERATION SEQUENCING MARKET SHARE, BY END USER, 2020
    • FIGURE 17 ACADEMIC INSTITUTES & RESEARCH CENTERS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
  • 4.5 NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE NGS MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 1 NEXT-GENERATION SEQUENCING MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Advancements in NGS platforms
        • 5.2.1.1.1 iSeq 100 System
        • 5.2.1.1.2 Ion GeneStudio S5
      • 5.2.1.2 Declining costs of genome sequencing
    • FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2020
      • 5.2.1.3 Improving regulatory and reimbursement scenario for NGS-based diagnostic tests
      • 5.2.1.4 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
    • TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 End-user budget constraints in developing countries
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Government & private support for large-scale sequencing
    • TABLE 3 GLOBAL SEQUENCING INITIATIVES
      • 5.2.3.2 Application of NGS in precision medicine and molecular diagnostics
      • 5.2.3.3 NGS data analysis using big data
    • FIGURE 21 DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING, 2001-2019
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Interpretation of complex data from NGS platforms
      • 5.2.4.2 Ethical issues
      • 5.2.4.3 Introduction of alternative technologies
    • 5.2.5 INDUSTRY TRENDS
      • 5.2.5.1 Development of portable sequencing technologies
      • 5.2.5.2 Partnerships & collaborations for technological advancements in NGS
    • TABLE 4 PARTNERSHIPS & COLLABORATIONS, JANUARY 2018-MARCH 2021
  • 5.3 IMPACT OF THE COVID-19 OUTBREAK ON THE NEXT-GENERATION SEQUENCING MARKET
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 NEXT-GENERATION SEQUENCING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT OF NEW ENTRANTS
    • 5.4.2 THREAT OF SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF SUPPLIERS
    • 5.4.4 BARGAINING POWER OF BUYERS
    • 5.4.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 22 VALUE CHAIN ANALYSIS OF THE NEXT-GENERATION SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
    • FIGURE 23 VALUE CHAIN: NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW -MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND ANALYSIS PHASES
  • 5.6 TECHNOLOGICAL ANALYSIS
    • TABLE 6 SANGER SEQUENCING VS. NGS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 24 ECOSYSTEM ANALYSIS: NEXT-GENERATION SEQUENCING MARKET
    • TABLE 7 SUPPLY CHAIN ECOSYSTEM
  • 5.8 PATENT ANALYSIS
    • FIGURE 25 PATENT APPLICATIONS FOR NEXT-GENERATION SEQUENCING, JANUARY 2010-DECEMBER 2020
  • 5.9 PRICING ANALYSIS
    • TABLE 8 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY REGION (2020)
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 NORTH AMERICA
      • 5.10.1.1 US
    • TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.10.1.2 Canada
    • 5.10.2 EUROPE
    • 5.10.3 ASIA PACIFIC
      • 5.10.3.1 China
    • TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.10.3.2 Japan
      • 5.10.3.3 India
    • 5.10.4 LATIN AMERICA
    • 5.10.5 MIDDLE EAST

6 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 12 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
  • 6.2 NGS CONSUMABLES
    • 6.2.1 GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL THE DEMAND FOR NGS CONSUMABLES
    • TABLE 13 NGS CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 14 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 15 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 16 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 17 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.3 SEQUENCING SERVICES
    • TABLE 18 NGS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 19 SEQUENCING SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 20 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 21 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 22 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 23 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
      • 6.3.1.1 Development of technologically advanced NGS products & services to propel the market growth
    • TABLE 24 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 25 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 26 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 27 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 28 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.2 WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING
      • 6.3.2.1 Reducing whole-genome sequencing costs to propel the growth of this segment
    • TABLE 29 WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 30 NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 31 EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 32 ASIA PACIFIC: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 33 LATIN AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.3 RNA SEQUENCING
      • 6.3.3.1 Launch of advanced RNA products & services to drive market growth
    • TABLE 34 RNA SEQUENCING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 35 NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 36 EUROPE: RNA SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 38 LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.4 OTHER SEQUENCING SERVICES
    • TABLE 39 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 40 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 41 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 43 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.4 PRESEQUENCING PRODUCTS & SERVICES/SAMPLE PREPARATION
    • TABLE 44 PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 45 PRESEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 46 NORTH AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 47 EUROPE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 48 ASIA PACIFIC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 49 LATIN AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.4.1 LIBRARY PREPARATION & TARGET ENRICHMENT
      • 6.4.1.1 Development of advanced library preparation solutions to drive market growth
    • TABLE 50 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 52 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 53 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 54 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.4.2 QUALITY CONTROL
      • 6.4.2.1 Importance of the quality control step in the NGS workflow is the major factor driving market growth
    • TABLE 55 QUALITY CONTROL MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 56 NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 57 EUROPE: QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 58 ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 59 LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.5 NGS PLATFORMS
    • 6.5.1 NGS PLATFORMS MARKET HAS EXPERIENCED A SIGNIFICANT TRANSFORMATION DUE TO THE ENTRY OF NEW PLAYERS
    • TABLE 60 NGS PLATFORMS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 61 NGS PLATFORMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 62 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 63 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 65 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.5.2 ILLUMINA
    • TABLE 66 ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 67 ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.5.2.1 NovaSeq Systems
    • TABLE 68 NOVASEQ SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.5.2.2 NextSeq Systems
    • TABLE 69 NEXTSEQ SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.5.2.3 MiSeq Systems
    • TABLE 70 MISEQ SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.5.2.4 iSeq 100 Systems
    • TABLE 71 ISEQ 100 SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.5.3 THERMO FISHER SCIENTIFIC
    • TABLE 72 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 73 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.5.4 OXFORD NANOPORE TECHNOLOGIES
    • TABLE 74 OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.5.5 PACIFIC BIOSCIENCES
    • TABLE 75 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.5.6 OTHER NGS PLATFORMS
    • TABLE 76 OTHER NGS PLATFORMS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.6 BIOINFORMATICS
    • TABLE 77 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 78 BIOINFORMATICS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 79 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 80 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 81 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 82 LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.6.1 NGS DATA ANALYSIS SERVICES
      • 6.6.1.1 Rising awareness about NGS data analysis services is the major factor supporting market growth
    • TABLE 83 NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 84 NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 85 EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 86 ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 87 LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.6.2 NGS DATA ANALYSIS SOFTWARE & WORKBENCHES
      • 6.6.2.1 Development of advanced bioinformatics solutions to drive the growth of this segment
    • TABLE 88 NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 89 NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 90 EUROPE: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 91 ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 92 LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.6.3 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS
      • 6.6.3.1 Launch of cloud-based solutions to drive the market
    • TABLE 93 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 94 NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 95 EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 97 LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.7 SERVICES FOR NGS PLATFORMS
    • 6.7.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET GROWTH
    • TABLE 98 SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 99 NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 100 EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 102 LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

7 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 103 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
    • TABLE 104 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
  • 7.2 SEQUENCING BY SYNTHESIS
    • 7.2.1 SBS TECHNOLOGY ENABLES THE HIGHEST PRODUCTION OF BASE PAIRS IN A SHORT PERIOD OF TIME
    • TABLE 105 SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 106 NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 107 EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 109 LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 ION SEMICONDUCTOR SEQUENCING
    • 7.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE SOME OF THE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING
    • TABLE 110 ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 111 NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 112 EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 114 LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 NANOPORE SEQUENCING
    • 7.4.1 NANOPORE SEQUENCING IS THE ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
    • TABLE 115 NANOPORE SEQUENCING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 116 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 117 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 119 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.5 SINGLE-MOLECULE REAL-TIME SEQUENCING
    • 7.5.1 SMRT SEQUENCING PRODUCES RESULTS IN A SHORT TIME AND AT LOWER COSTS
    • TABLE 120 SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 121 NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 122 EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 123 ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 124 LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.6 OTHER SEQUENCING TECHNOLOGIES
    • TABLE 125 OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 126 NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 127 EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 128 ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 129 LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

8 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 130 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 8.2 DIAGNOSTICS
    • TABLE 131 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 132 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 133 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 134 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 136 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 8.2.1 CANCER DIAGNOSTICS
      • 8.2.1.1 Growing number of new cancer cases to propel market growth
    • TABLE 137 FUNDING FOR CANCER RESEARCH BY AMERICAN CANCER SOCIETY (AS OF MARCH 2021)
    • TABLE 138 NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 139 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 140 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 142 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 8.2.2 INFECTIOUS DISEASE DIAGNOSTICS
      • 8.2.2.1 Increasing demand for NGS products for infectious disease diagnostics to drive market growth
    • TABLE 143 NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 144 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 145 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 147 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 8.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS
      • 8.2.3.1 Increasing awareness about the benefits of NIPT to propel market growth
    • TABLE 148 NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 149 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 150 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 151 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 152 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 8.2.4 OTHER DIAGNOSTIC APPLICATIONS
    • TABLE 153 NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 154 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 155 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 157 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 DRUG DISCOVERY
    • 8.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS FOR DRUG DISCOVERY TO SUPPORT MARKET GROWTH
    • TABLE 158 NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 159 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 160 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 162 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 AGRICULTURAL & ANIMAL RESEARCH
    • 8.4.1 GROWING FUNDING & SUPPORT FOR ANIMAL & PLANT GENOMICS RESEARCH TO DRIVE MARKET GROWTH
    • TABLE 163 NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 164 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 165 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 166 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 167 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 OTHER APPLICATIONS
    • TABLE 168 NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 169 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 170 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 171 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 172 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)

9 NEXT-GENERATION SEQUENCING MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 173 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 ACADEMIC INSTITUTES & RESEARCH CENTERS
    • 9.2.1 DEVELOPMENT OF COST-EFFECTIVE NGS PRODUCTS & SERVICES FOR RESEARCHERS TO PROPEL MARKET GROWTH
    • TABLE 174 NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 175 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 176 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 177 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 178 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.3.1 GROWING AGREEMENTS & COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMA & BIOTECH COMPANIES TO DRIVE MARKET GROWTH
    • TABLE 179 NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 180 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 181 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 182 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 183 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.4 HOSPITALS & CLINICS
    • 9.4.1 DEVELOPMENT OF ADVANCED NGS-BASED DIAGNOSTIC SOLUTIONS TO DRIVE THE ADOPTION OF NGS IN HOSPITALS & CLINICS
    • TABLE 184 NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 185 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 186 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 187 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 188 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 189 NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 190 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 191 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 192 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 193 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)

10 NEXT-GENERATION SEQUENCING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 194 NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 26 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
    • TABLE 195 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 196 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 197 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 198 NORTH AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 199 NORTH AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 200 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 201 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 202 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 203 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Growing R&D activities in the US to drive market growth
    • TABLE 204 US: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 205 US: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 206 US: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 207 US: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 208 US: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 209 US: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 210 US: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 211 US: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing government initiatives in genomics research will boost the adoption of NGS
    • TABLE 212 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 213 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 214 CANADA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 215 CANADA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 216 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 217 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 218 CANADA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 219 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 220 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 221 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 222 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 223 EUROPE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 224 EUROPE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 225 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 226 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 227 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 228 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany dominates the European next-generation sequencing market
    • TABLE 229 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 230 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 231 GERMANY: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 232 GERMANY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 233 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 234 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 235 GERMANY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 236 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Favorable funding scenario for genomics research in the country to support the adoption of NGS
    • TABLE 237 UK: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 238 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 239 UK: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 240 UK: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 241 UK: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 242 UK: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 243 UK: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 244 UK: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Government initiatives to support genomics research-a major factor driving market growth in France
    • TABLE 245 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 246 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 247 FRANCE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 248 FRANCE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 249 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 250 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 251 FRANCE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 252 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Favorable funding scenario to drive the next-generation sequencing market in Italy
    • TABLE 253 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 254 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 255 ITALY: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 256 ITALY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 257 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 258 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 259 ITALY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 260 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing number of conferences focusing on NGS to support market growth in Spain
    • TABLE 261 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 262 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 263 SPAIN: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 264 SPAIN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 265 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 266 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 267 SPAIN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 268 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.6 NETHERLANDS
      • 10.3.6.1 Large number of conferences and workshops focusing on NGS technologies to boost the NGS market in the Netherlands
    • TABLE 269 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 270 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 271 NETHERLANDS: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 272 NETHERLANDS: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 273 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 274 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 275 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 276 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 277 ROE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 278 ROE: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 279 ROE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 280 ROE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 281 ROE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 282 ROE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 283 ROE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 284 ROE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 27 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
    • TABLE 285 APAC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 286 APAC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 287 APAC: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 288 APAC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 289 APAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 290 APAC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 291 APAC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 292 APAC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 293 APAC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 China to register the highest growth in the APAC NGS market
    • TABLE 294 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 295 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 296 CHINA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 297 CHINA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 298 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 299 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 300 CHINA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 301 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 High incidence of genetic disorders in the country has resulted in the increased adoption of NGS
    • TABLE 302 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 303 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 304 JAPAN: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 305 JAPAN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 306 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 307 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 308 JAPAN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 309 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growing prevalence of target diseases in India to support market growth
    • TABLE 310 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 311 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 312 INDIA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 313 INDIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 314 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 315 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 316 INDIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 317 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth
    • TABLE 318 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 319 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 320 AUSTRALIA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 321 AUSTRALIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 322 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 323 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 324 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 325 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 326 ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 327 ROAPAC: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 328 ROAPAC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 329 ROAPAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 330 ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 331 ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 332 ROAPAC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 333 ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 334 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 335 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 336 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 337 LATIN AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 338 LATIN AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 339 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 340 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 341 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 342 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 High prevalence of HIV in Brazil to drive the demand for NGS
    • TABLE 343 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 344 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 345 BRAZIL: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 346 BRAZIL: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 347 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 348 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 349 BRAZIL: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 350 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Economic growth in Mexico to support the growth of the NGS market
    • TABLE 351 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 352 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 353 MEXICO: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 354 MEXICO: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 355 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 356 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 357 MEXICO: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 358 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 359 ROLA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 360 ROLA: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 361 ROLA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 362 ROLA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 363 ROLA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 364 ROLA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 365 ROLA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 366 ROLA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 LAUNCH OF GENOMIC PROGRAMS TO SUPPORT MARKET GROWTH
    • TABLE 367 MEA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 368 MEA: SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 369 MEA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 370 MEA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 371 MEA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 372 MEA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 373 MEA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 374 MEA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET EVALUATION FRAMEWORK
    • TABLE 375 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES-MAJOR GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 28 NEXT-GENERATION SEQUENCING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
  • 11.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE NEXT-GENERATION SEQUENCING MARKET
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 30 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 31 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
  • 11.7 COMPANY PRODUCT FOOTPRINT
    • TABLE 376 PRODUCT PORTFOLIO ANALYSIS: NEXT-GENERATION SEQUENCING MARKET (2020)
  • 11.8 COMPANY GEOGRAPHIC FOOTPRINT
    • TABLE 377 GEOGRAPHIC REVENUE MIX: NEXT-GENERATION SEQUENCING MARKET (2020)
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 NEXT-GENERATION SEQUENCING MARKET: PRODUCT LAUNCHES
    • 11.9.2 NEXT-GENERATION SEQUENCING MARKET: DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 ILLUMINA, INC.
    • TABLE 378 ILLUMINA: BUSINESS OVERVIEW
    • FIGURE 32 ILLUMINA: COMPANY SNAPSHOT (2020)
    • 12.1.2 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 379 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
    • 12.1.3 BGI GROUP
    • TABLE 380 BGI GROUP: BUSINESS OVERVIEW
    • 12.1.4 PERKINELMER
    • TABLE 381 PERKINELMER: BUSINESS OVERVIEW
    • FIGURE 34 PERKINELMER: COMPANY SNAPSHOT (2020)
    • 12.1.5 QIAGEN N.V.
    • TABLE 382 QIAGEN: BUSINESS OVERVIEW
    • FIGURE 35 QIAGEN: COMPANY SNAPSHOT (2020)
    • 12.1.6 F. HOFFMANN-LA ROCHE AG
    • TABLE 383 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
    • FIGURE 36 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2020)
    • 12.1.7 EUROFINS SCIENTIFIC
    • TABLE 384 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 37 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
    • 12.1.8 AGILENT TECHNOLOGIES, INC.
    • TABLE 385 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 38 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
    • 12.1.9 PACIFIC BIOSCIENCES
    • TABLE 386 PACIFIC BIOSCIENCES: BUSINESS OVERVIEW
    • FIGURE 39 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT (2020)
    • 12.1.10 OXFORD NANOPORE TECHNOLOGIES
    • TABLE 387 OXFORD NANOPORE TECHNOLOGIES: BUSINESS OVERVIEW
    • 12.1.11 GENEWIZ (A PART OF BROOKS AUTOMATION)
    • TABLE 388 GENEWIZ: BUSINESS OVERVIEW
    • FIGURE 40 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2020)
    • 12.1.12 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN)
    • TABLE 389 PSOMAGEN: BUSINESS OVERVIEW
    • 12.1.13 10X GENOMICS
    • TABLE 390 10X GENOMICS: BUSINESS OVERVIEW
    • 12.1.14 NUGEN TECHNOLOGIES (A PART OF THE TECAN GROUP)
    • TABLE 391 NUGEN TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 41 TECAN GROUP: COMPANY SNAPSHOT (2020)
    • 12.1.15 ZYMO RESEARCH
    • TABLE 392 ZYMO RESEARCH: BUSINESS OVERVIEW
    • 12.1.16 TAKARA BIO
    • TABLE 393 TAKARA BIO: BUSINESS OVERVIEW
    • FIGURE 42 TAKARA BIO: COMPANY SNAPSHOT (2021)
  • 12.2 OTHER COMPANIES
    • 12.2.1 HAMILTON COMPANY
    • 12.2.2 BECKMAN COULTER (A SUBSIDIARY OF DANAHER CORPORATION)
    • 12.2.3 BECTON, DICKINSON AND COMPANY
    • 12.2.4 GENOTYPIC TECHNOLOGY
    • 12.2.5 LUCIGEN CORPORATION

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q